<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203685/" ref="ordinalpos=757&amp;ncbi_uid=3512229&amp;link_uid=PMC3203685" image-link="/pmc/articles/PMC3203685/figure/F1/" class="imagepopup">Figure 1. PI3K/Akt/mTOR <span class="highlight" style="background-color:">signaling</span> cascade.  From: Summary of the Proceedings from the 10th Annual Meeting of Molecularly Targeted Therapy in NSCLC. </a></div><br /><div class="p4l_captionBody">Signaling through a transmembrane receptor activates the PI3K signaling network to phosphorylate Akt and promote cell proliferation and invasion through mTOR. Multiple feedback loops exist within this signaling cascade, and a number of inhibitors are in development to target this pathway in cancer.</div></div>